Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1376 of 5804
-
Can a single dose of immunotherapy before surgery help fight recurrent brain tumors?
Disease control Recruiting nowThis is to study if neoadjuvant atezolizumab therapy is beneficial for patients with recurrent glioblastoma and a low mutational burden.
Phase: PHASE2 • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Brain shield for heart patients: new device tested in TAVR procedure
Disease control CompletedThe goal of this prospective, multi-center, randomized, controlled study is to compare the safety and efficacy of the ProtEmbo Cerebral Embolic Protection device to a hybrid control (no embolic protection device ('No Device') and the Sentinel device) in subjects with severe sympt…
Phase: NA • Sponsor: Protembis GmbH • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Magnetic map may improve cancer staging
Diagnosis OngoingThis is a multi-centre, partially blinded, side-by-side comparator study to assess the safety and tolerability, feasibility, and potential added diagnostic and clinical value of using the FerroTrace® and FerroMag Sentinel Lymph Node Mapping (SLNM) System for mapping sentinel lymp…
Phase: NA • Sponsor: Ferronova Pty Ltd • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
New pill could tame lung inflammation in sarcoidosis
Disease control Recruiting nowThis is a Phase 2, randomized, double-blind, placebo-controlled, adaptive, multicenter study to evaluate the efficacy, safety, tolerability, Pharmacodynamics (PD), and Pharmacokinetics (PK) of OATD-01 in the treatment of subjects with active pulmonary sarcoidosis.
Phase: PHASE2 • Sponsor: Molecure S.A. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can the shingles vaccine protect transplant patients? new study aims to find out
⭐️ VACCINE ⭐️ Recruiting nowThe goal of this clinical trial is to compare responses to Varicella Zoster vaccination between transplant patients on different medication regimens, and their healthy co-habitants. The main questions it aims to answer are: 1. Are there differences in vaccination immunological r…
Phase: NA • Sponsor: Central Adelaide Local Health Network Incorporated • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:05 UTC
-
Brain zaps boost OCD therapy in youth trial
Symptom relief OngoingThe goal of this clinical trial is to compare different forms of transcranial magnetic stimulation (TMS) for improving the outcomes of Exposure with Response Prevention (ERP) in youth and young adults with Obsessive-Compulsive Disorder (OCD). Researchers will compare three groups…
Phase: NA • Sponsor: Bradley Hospital • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
New drug switch may control lung cancer longer in High-Risk patients
Disease control CompletedIn this study, the researchers will look at whether having participants switch from durvalumab to sotorasib when they have detectable minimal residual disease (MRD) is an effective treatment approach for locally advanced non-small cell lung cancer (LA-NSCLC). The researchers will…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Zapping the vagus nerve during meditation may help fight alcohol cravings
Disease control Recruiting nowOur primary objective is to integrate tVNS and mindfulness meditation within a structured mindfulness-based relapse prevention (MBRP) program for detoxified alcohol-dependent patients (AD). We aim to determine whether neuromodulation can enhance mindfulness-based relapse preventi…
Phase: NA • Sponsor: Charite University, Berlin, Germany • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
VR headset could help treat OCD symptoms
Symptom relief Recruiting nowThe aim of this study is to evaluate the efficacy of virtual reality exposure therapy (VRET) as a treatment for obsessive-compulsive disorder (OCD). This study focuses on patients receiving treatment in outpatient psychiatry or clinical psychology settings, utilizing a within-sub…
Phase: NA • Sponsor: National Institute of Mental Health, Czech Republic • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Higher defibrotide doses may help severe transplant complication
Disease control Recruiting nowThis research study is being done to determine the safety and tolerability of increasing doses of defibrotide within a single patient with sinusoidal obstructive syndrome (SOS)/veno-occlusive disease (VOD) after hematopoietic cell transplantation (HCT) associated with either kidn…
Phase: PHASE2 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New meningitis vaccine shows promise for infants in major trial
⭐️ VACCINE ⭐️ CompletedThis study is conducted to support a 2-dose series (1+1 vaccination schedule) for immunization of individuals from 6 months of age. The study is designed to evaluate the non-inferiority of the immunological response of MenACYW conjugate vaccine to Nimenrix® after the completion o…
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:01 UTC
-
New drug aims to quiet MS brain lesions
Disease control OngoingThe main purpose of this study is to evaluate the safety and efficacy of LY3541860 in adult participants with multiple sclerosis that gets worse and gets better. The study will last about 9 months with additional 6 months follow-up.
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Virtual diet program aims to stop obesity in young leukemia patients
Prevention Recruiting nowThe purpose of this study is determine the effectiveness of a six-month virtually-delivered dietary education intervention (PEDALL) on the prevention of overweight and obesity (OW/OB) during maintenance chemotherapy in children and adolescents with acute lymphoblastic leukemia (A…
Phase: NA • Sponsor: Columbia University • Aim: Prevention
Last updated Jun 27, 2026 07:53 UTC
-
Glow-in-the-Dark dye could prevent surgical accidents
Symptom relief CompletedThe ureter is the tube that carries urine from the kidneys to the bladder. It is difficult for surgeons to see the ureter during abdominal surgery. This could lead to injuring the ureter which, although rare, could be serious. This study is about a potential new medical dye, cal…
Phase: PHASE3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
New experimental drug CTX-8371 enters first human tests for tough cancers
Disease control Recruiting nowThis is a Phase 1, open-label, first-in-human study of CTX-8371 administered as a monotherapy in patients with metastatic or locally advanced malignancies. The study will be conducted in 2 cohorts: Dose Escalation and Dose Expansion.
Phase: PHASE1 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Your voice may reveal hidden depression: new study tests speech screening
Diagnosis CompletedMajor depressive disorder (MDD) and anxiety are increasingly prevalent among university student populations, yet early detection remains reliant on psychometric instruments tied to diagnostic criteria (e.g., PHQ-9, GAD). Emerging evidence suggests that depression affects both the…
Sponsor: Accexible • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Engineered immune cells take on Hard-to-Treat blood cancers
Disease control Recruiting nowThis phase I trial tests safety, side effects and best dose of B-cell activating factor receptor (BAFFR)-based chimeric antigen receptor T-cells, with fludarabine and cyclophosphamide lymphodepletion, for the treatment of patients with B-cell hematologic malignancies that has com…
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Vision therapy may unlock social skills in children with autism
Symptom relief CompletedChildren with autism spectrum disorder (ASD) often have visual problems that add difficulty to social interaction and communication. This study implemented a visual rehabilitation program to improve visual function and functional use of visual information in children with ASD and…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New oral esketamine pill shows promise for stubborn depression
Symptom relief CompletedThe study is a Phase 2, double-blind, randomized, placebo-controlled study in Major Depressive Disorder (MDD) participants with an inadequate response to standard antidepressants The objective of the study is to assess CLE-100 (oral esketamine) for the treatment of MDD in partici…
Phase: PHASE2 • Sponsor: Clexio Biosciences Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Gout drug study aims for fewer infusions, same relief
Disease control CompletedThe study consists of 24-week double-blind trial to evaluate the non-inferiority of the efficacy and safety of pegloticase Q4W with MTX versus pegloticase Q2W with MTX, followed by a 24-week open-label extension of pegloticase Q4W with MTX, in participants with uncontrolled refra…
Phase: PHASE4 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC